Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/imaging-of-gastrointestinal-tract-tumors/bruneton/descriptif_2303717
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=2303717

Imaging of Gastrointestinal Tract Tumors, Softcover reprint of the original 1st ed. 1990

Langue : Français

Auteur :

Préfacier : Delmont J.

Couverture de l’ouvrage Imaging of Gastrointestinal Tract Tumors
Imaging of Gastrointestinal Tract Tumors describes current imaging practice for the most commonly encountered benign and malignant digestive tract tumors and gives a review of the literature for less frequent tumors. General features (anatomic data, frequency, clinical and biologic signs, treatment) are discussed for all pathologies prior to description of imaging techniques, which include barium studies, ultrasonography and angiography, and above all CT. MRI appears particularly indicated for esophageal carcinoma and pelvic recurrences of colorectal cancers. The book is divided into three main section - benign tumors, malignant tumors, and tumors with an indeterminate prognosis - reflecting the value of different imaging strategies as a function of a tumor's natural history. The thorough analysis of literature for both frequent and less common tumors allows global evaluation of the diagnostic possibilities of imaging techniques, making Imaging of Gastrointestinal TractTumors a reference work for all specialists concerned with digestive tract pathologies.
Benign Tumors.- 1 Benign Epithelial Tumors.- 1.1 Esophagus.- 1.1.1 General Features.- 1.1.2 Imaging.- 1.2 Stomach.- 1.2.1 General Features.- 1.2.2 Imaging.- 1.2.3 Differential Diagnosis.- 1.3 Small Intestine.- 1.3.1 General Features.- 1.3.2 Imaging.- 1.3.3 Differential Diagnosis.- 1.4 Colon and Rectum.- 1.4.1 General Features.- 1.4.2 Imaging.- 1.4.3 Differential Diagnosis.- 1.4.4 Conclusion.- 1.5 References.- 2 Polyposis.- 2.1 Hereditary Polyposis Syndromes.- 2.1.1 Familial Multiple Polyposis.- 2.1.2 Other Hereditary Polypses.- 2.2 Non-hereditary Polyposes.- 2.2.1 Proliferation of Hyperplastic Polyps.- 2.2.2 Cronkhite-Canada Syndrome.- 2.2.3 Differential Diagnosis.- 2.3 References.- 3 Leiomyoma.- 3.1 Esophagus.- 3.1.1 General Features.- 3.1.2 Imaging.- 3.2 Stomach.- 3.2.1 General Features.- 3.2.2 Imaging.- 3.3 Small Intestine.- 3.3.1 General Features.- 3.3.2 Imaging.- 3.4 Colon and Rectum.- 3.4.1 General Features.- 3.4.2 Imaging.- 3.5 Conclusion.- 3.6 References.- 4 Lipoma.- 4.1 General Anatomic Features.- 4.2 Esophagus.- 4.3 Stomach.- 4.4 Small Intestine.- 4.5 Colon and Rectum.- 4.6 References.- 5 Benign Neurogenic Tumors.- 5.1 Neurogenic Gastric Tumors (Excluding von Recklinghausen’s Disease).- 5.1.1 General Features.- 5.1.2 Imaging.- 5.2 Neurogenic Intestinal Tumors (Excluding von Recklinghausen’s Disease).- 5.2.1 General Features.- 5.2.2 Imaging.- 5.3 Solitary Benign Neurogenic Tumors of the Esophagus, Colon, and Rectum.- 5.3.1 Esophagus.- 5.3.2 Colon and Rectum.- 5.4 Benign Neurogenic Tumors in von Recklinghausen’s Disease.- 5.4.1 Gastric Involvement by von Recklinghausen’s Disease.- 5.4.2 Intestinal Involvement by von Recklinghausen’s Disease.- 5.5 Granular Cell Tumors.- 5.5.1 General Features.- 5.5.2 Esophagus.- 5.6 References.- 6 Benign Vascular Tumors.- 6.1 General Features.- 6.2 Gastrointestinal Hemangiomas.- 6.2.1 Esophagus.- 6.2.2 Stomach.- 6.2.3 Small Intestine.- 6.2.4 Colon and Rectum.- 6.3 Lymphangiomas.- 6.4 References.- 7 Benign Fibrous Tumor Tissues.- 7.1 Esophagus.- 7.2 Stomach.- 7.3 Small Intestine.- 7.4 Colon and Rectum.- 7.5 Conclusion.- 7.6 References.- 8 Aberrant Pancreas.- 8.1 General Features.- 8.2 Imaging.- 8.3 Conclusion.- 8.4 References.- 9 Endometriosis.- 9.1 General Features.- 9.2 Imaging.- 9.3 References.- Malignant Tumors.- 10 Carcinoma of the Esophagus.- 10.1 Pathology.- 10.1.1 Epidemiology.- 10.1.2 Pathogenesis.- 10.2 Anatomic Features.- 10.2.1 Macroscopic Features.- 10.2.2 Location.- 10.2.3 Histology.- 10.2.4 Patterns of Spread.- 10.2.5 Evolution.- 10.2.6 TNM Classification.- 10.3 Clinical Symptoms and Endoscopy.- 10.3.1 Clinical Symptoms.- 10.3.2 Endoscopy.- 10.4 Diagnostic Imaging.- 10.4.1 Standard Chest X-rays.- 10.4.2 Barium Esophagography.- 10.4.3 Computed Tomography.- 14.4.4 Ultrasonography.- 10.4.5 Other Techniques.- 10.5 Prognostic Factors.- 10.6 Therapeutic Options.- 10.6.1 Surgery.- 10.6.2 Radiotherapy.- 10.6.3 Local Palliative Therapy.- 10.7 Post-therapy Imaging Studies and Diagnosis of Complications.- 10.7.1 Normal Postoperative Appearance.- 10.7.2 Early Postoperative Complications.- 10.7.3 Late Postoperative Complications.- 10.7.4 Surveillance After Radiotherapy.- 10.7.5 Surveillance After Other Types of Treatment.- 10.8 Adenocarcinoma of the Esophagus.- 10.8.1 Radiographic Features.- 10.8.2 Differences Between Adenocarcinoma and Epidermoid Cancer of the Esophagus 102 10.8.3 Adenocarcinoma of the Esophagus and Gastric Adenocarcinoma.- 10.9 Conclusion.- 10.10 References.- 11 Adenocarcinoma of the Stomach.- 11.1 Epidemiology.- 11.1.1 Frequency.- 11.2 Pathogenesis.- 11.2.1 Endogenous Factors.- 11.2.2 Environmental Factors.- 11.3 Pathologic Findings.- 11.3.1 Gross Anatomy.- 11.3.2 Microscopic Features.- 11.3.3 Mode of Spread.- 11.3.4 Classifications of Gastric Adenocarcinoma.- 11.4 Diagnostic Data Other than Imaging.- 11.4.1 Circumstances of Discovery and Screening.- 11.4.2 Clinical Symptoms.- 11.4.3 Endoscopy.- 11.5 Imaging Studies.- 11.5.1 Contrast Studies.- 11.5.2 Ultrasonography.- 11.5.3 Computed Tomography.- 11.6 Treatment and Prognosis.- 11.6.1 Surgical Management of Gastric Adenocarcinoma.- 11.6.2 Radiotherapy.- 11.6.3 Chemotherapy.- 11.6.4 Indications.- 11.6.5 Prognostic Factors.- 11.6.6 Survival.- 11.7 Patient Follow-up.- 11.7.1 Clinical Pictures and Frequency of Complications.- 11.7.2 Disease Recurrence.- 11.7.3 Follow-up Algorithm.- 11.7.4 Imaging Studies for Follow-up of Patients with Gastric Adenocarcinoma.- 11.8 Cancer of the Cardia.- 11.8.1 General Features.- 11.8.2 Imaging.- 11.9 Conclusion.- 11.10 References.- 12 Adenocarcinoma of the Small Intestine.- 12.1 General Features.- 12.2 Imaging.- 12.3 Conclusion.- 12.4 References.- 13 Adenocarcinoma of the Colon and Rectum.- 13.1 General Features.- 13.1.1 Epidemiology.- 13.1.2 Pathologic Anatomy.- 13.1.3 Clinical Study.- 13.1.4 Diagnosis by Non-imaging Techniques.- 13.1.5 Therapeutic Options.- 13.1.6 Results and Prognosis.- 13.2 Pretherapy Staging of Colorectal Adenocarcinomas.- 13.2.1 Barium Enema Examination.- 13.2.2 Ultrasonography.- 13.2.3 Computed Tomography.- 13.3 Post-therapy Follow-up.- 13.3.1 Post-therapy Follow-up Examinations.- 13.3.2 Anterior Resection.- 13.3.3 Abdominoperineal Resection.- 13.3.4 Pelvic Exenteration.- 13.3.5 Hepatic Metastases.- 13.3.6 Non-curative Treatment.- 13.4 Screening for Colorectal Cancer.- 13.4.1 Occult Fecal Blood Tests.- 13.4.2 High-risk Patients.- 13.5 References.- 14 Cancer of the Anal Canal.- 14.1 Epidemiology.- 14.2 Pathogenesis.- 14.2.1 Gross Features.- 14.2.2 Histology.- 14.2.3 Mode of Spread.- 14.2.4 Histoprognosis.- 14.3 Clinical Features.- 14.4 Imaging.- 14.5 Treatment.- 14.5.1 Radiotherapy.- 14.5.2 Surgery.- 14.5.3 Therapeutic Options.- 14.5.4 Post-therapy Follow-up.- 14.6 Conclusion.- 14.7 References.- 15 Leiomyosarcoma.- 15.1 Esophagus.- 15.1.1 General Features.- 15.1.2 Imaging.- 15.2 Stomach.- 15.2.1 General Features.- 15.2.2 Imaging.- 15.3 Small Intestine.- 15.3.1 General Features.- 15.3.2 Imaging.- 15.4 Colon and Rectum.- 15.4.1 General Features.- 15.4.2 Imaging.- 15.5 Conclusion.- 15.6 References.- 16 Lymphomas.- 16.1 Non-Hodgkin’s Lymphoma.- 16.1.1 Esophagus.- 16.1.2 Stomach.- 16.1.3 Small Intestine.- 16.1.4 Colon and Rectum.- 16.2 Hodgkin’s Disease.- 16.2.1 Esophagus.- 16.2.2 Stomach.- 16.2.3 Small Intestine.- 16.2.4 Colon and Rectum.- 16.3 Conclusion.- 16.4 References.- 17 Metastases.- 17.1 Esophagus.- 17.1.1 Clinical Features.- 17.1.2 Radiologic Features.- 17.2 Stomach.- 17.2.1 Clinical Features.- 17.2.2 Radiologic Features.- 17.3 Small Intestine.- 17.3.1 Clinical Features.- 17.3.2 Radiologis Features.- 17.4 Colon and Rectum.- 17.4.1 Clinical Features.- 17.4.2 Radiologic Features.- 17.5 Conclusion.- 17.6 References.- 18 Kaposi’s Sarcoma.- 18.1 General Features.- 18.2 Imaging.- 18.3 References.- 19 Malignant Neurogenic Tumors.- 19.1 Stomach (Excluding von Recklinghausen’s Disease).- 19.1.1 General Features.- 19.1.2 Imaging.- 19.2 Small Intestine (Excluding von Recklinghausen’s Disease).- 19.2.1 General Features.- 19.2.2 Imaging.- 19.3 Malignant Neurogenic Tumors in von Recklinghausen’s Disease.- 19.4 References.- 20 Primary Malignant Melanoma of the Gastrointestinal Tract.- 20.1 Pathology.- 20.2 General Features.- 20.3 Gastrointestinal Sites.- 20.4 Primary Melanoma of the Esophagus.- 20.5 Anorectal Melanoma.- 20.6 Conclusion.- 20.7 References.- 21 Malignant Fibrous Histiocytoma.- 21.1 General Features.- 21.2 Imaging.- 21.3 Conclusion.- 21.4 References.- Tumors with an Indeterminate Prognosis.- 22 Carcinoid Tumors.- 22.1 General Features.- 22.1.1 Gross Features.- 22.1.2 Clinical Features.- 22.1.3 Diagnosis by Techniques Other than Imaging.- 22.1.4 Evolution and Prognosis.- 22.2 Imaging.- 22.2.1 Small Intestine.- 22.2.2 Rectum.- 22.2.3 Colon.- 22.2.4 Stomach.- 22.2.5 Other Anatomic Sites.- 22.3 Conclusion.- 22.4 References.- 23 Leiomyoblastoma.- 23.1 Stomach.- 23.1.1 General Features.- 23.1.2 Imaging.- 23.2 Extragastric Sites.- 23.3 References.- 24 Hemangiopericytoma.- 24.1 General Features.- 24.2 Imaging.- 24.3 Conclusion.- 24.4 References.- 25 Subject Index.

Date de parution :

Ouvrage de 281 p.

17x24.4 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 52,74 €

Ajouter au panier